UnitedHealth Group Inc (UNH) Position Increased by Clarius Group LLC

Clarius Group LLC increased its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 28.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,344 shares of the healthcare conglomerate’s stock after purchasing an additional 522 shares during the period. Clarius Group LLC’s holdings in UnitedHealth Group were worth $584,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the company. Crewe Advisors LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at approximately $25,000. Pearl River Capital LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at approximately $35,000. Ipswich Investment Management Co. Inc. bought a new stake in UnitedHealth Group in the 4th quarter valued at approximately $40,000. OLD Second National Bank of Aurora lifted its stake in UnitedHealth Group by 70.0% in the 4th quarter. OLD Second National Bank of Aurora now owns 170 shares of the healthcare conglomerate’s stock valued at $42,000 after acquiring an additional 70 shares in the last quarter. Finally, Laurel Wealth Advisors LLC bought a new stake in UnitedHealth Group in the 4th quarter valued at approximately $42,000. Institutional investors and hedge funds own 86.68% of the company’s stock.

Shares of UNH stock traded up $4.91 during trading on Friday, reaching $221.75. 13,927,214 shares of the company’s stock were exchanged, compared to its average volume of 7,290,230. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.63. The firm has a market capitalization of $212.78 billion, a PE ratio of 17.22, a PEG ratio of 1.19 and a beta of 0.79. UnitedHealth Group Inc has a twelve month low of $208.07 and a twelve month high of $287.94.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share for the quarter, topping analysts’ consensus estimates of $3.60 by $0.13. The business had revenue of $60.30 billion for the quarter, compared to analyst estimates of $59.72 billion. UnitedHealth Group had a return on equity of 25.07% and a net margin of 5.45%. The firm’s revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.04 EPS. As a group, sell-side analysts predict that UnitedHealth Group Inc will post 14.7 EPS for the current fiscal year.

In related news, Director William C. Ballard, Jr. sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, January 22nd. The stock was sold at an average price of $266.61, for a total transaction of $1,333,050.00. Following the transaction, the director now directly owns 77,702 shares of the company’s stock, valued at approximately $20,716,130.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Gail R. Wilensky sold 2,930 shares of the business’s stock in a transaction that occurred on Thursday, March 14th. The stock was sold at an average price of $253.39, for a total value of $742,432.70. Following the transaction, the director now directly owns 64,726 shares in the company, valued at $16,400,921.14. The disclosure for this sale can be found here. Insiders have sold a total of 17,930 shares of company stock worth $4,587,133 over the last three months. 0.87% of the stock is owned by insiders.

Several research firms have commented on UNH. Stephens began coverage on UnitedHealth Group in a research note on Monday, January 14th. They issued an “overweight” rating and a $287.00 target price on the stock. ValuEngine cut UnitedHealth Group from a “hold” rating to a “sell” rating in a research note on Thursday. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $279.00 price objective on the stock in a research note on Saturday, January 5th. Barclays dropped their price objective on UnitedHealth Group from $290.00 to $270.00 and set an “overweight” rating on the stock in a research note on Wednesday. Finally, SunTrust Banks dropped their price objective on UnitedHealth Group to $300.00 and set a “buy” rating on the stock in a research note on Wednesday. They noted that the move was a valuation call. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and a consensus price target of $291.56.

COPYRIGHT VIOLATION WARNING: “UnitedHealth Group Inc (UNH) Position Increased by Clarius Group LLC” was posted by Baseball Daily News and is the property of of Baseball Daily News. If you are accessing this piece on another site, it was illegally stolen and republished in violation of U.S. & international copyright and trademark law. The correct version of this piece can be viewed at https://www.baseballdailydigest.com/news/2019/04/21/unitedhealth-group-inc-unh-holdings-boosted-by-clarius-group-llc.html.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

See Also: Why are analyst ratings important in trading stocks?

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.